Roche has teamed up with Loxo Oncology to develop a pan-tropomyosin receptor kinase immunohistochemistry test.
The FDA warned of a higher rate of cardiac events in patients receiving Abbott's Absorb stent compared to those treated with a metal stent.
MedLumics has raised $37 million to run clinical trials of its atrial fibrillation device.
Using instant wave-free ratio (iFR), a pressure-derived index, could lead to quicker, more cost-effective heart disease diagnoses and treatments.
GE Healthcare has bought wireless fetal monitoring business Monica Healthcare.
Siemens and HeartFlow have inked a deal to combine the former’s CT scanners with the latter’s noninvasive CAD test.
NICE has recommended the use of Boston Scientific’s CRT-D for the treatment of heart failure patients.
IBM Watson Health will integrate MedyMatch's decision support-tool into its imaging offerings.
AliveCor is launching a new platform to help physicians manage reports from its smartphone ECG recorder.
RenalGuard Solutions raised $14.5 million in a Series A round. The funds will support the pivotal trial of a device that protects the kidneys.